{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:04:34Z","timestamp":1791615874721,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00415-019-09425-7","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T12:02:52Z","timestamp":1560772972000},"page":"2334-2337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Update on human African trypanosomiasis (sleeping sickness)"],"prefix":"10.1007","volume":"266","author":[{"given":"Peter G. E.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"key":"9425_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","volume":"12","author":"PGE Kennedy","year":"2013","unstructured":"Kennedy PGE (2013) Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness) (2013). Lancet Neurol 12:186\u2013194. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(12)70296-X","journal-title":"Lancet Neurol"},{"key":"9425_CR2","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","volume":"390","author":"P B\u00fcscher","year":"2017","unstructured":"B\u00fcscher P, Cecchi G, Jamonneau V, Priotto G (2017) Human African trypanosomiasis. Lancet 390:2397\u20132409. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)31510-6","journal-title":"Lancet"},{"key":"9425_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1172\/JCI200421052","volume":"113","author":"PGE Kennedy","year":"2004","unstructured":"Kennedy PGE (2004) Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 113:496\u2013504. \n                    https:\/\/doi.org\/10.1172\/JCI200421052","journal-title":"J Clin Invest"},{"key":"9425_CR4","doi-asserted-by":"publisher","first-page":"e1859","DOI":"10.1371\/journal.pntd.0001859","volume":"6","author":"PP Simarro","year":"2012","unstructured":"Simarro PP, Cecchi G, Franco JR, Paone M, Diarra A, Ruiz-Postigo JA et al (2012) Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis 6:e1859. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0001859","journal-title":"PLoS Negl Trop Dis"},{"key":"9425_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1708-8305.2011.00576.x","volume":"19","author":"PP Simarro","year":"2012","unstructured":"Simarro PP, Franco JR, Cecchi G, Paone M, Diarra A, Ruiz Postigo JA et al (2012) Human African trypanosomiasis in non-endemic countries (2000\u20132010). J Travel Med 19:44\u201353. \n                    https:\/\/doi.org\/10.1111\/j.1708-8305.2011.00576.x","journal-title":"J Travel Med"},{"key":"9425_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.21429","volume":"64","author":"PGE Kennedy","year":"2008","unstructured":"Kennedy PGE (2008) The continuing problem of Human African trypanosomiasis (sleeping sickness). Ann Neurol 64:116\u2013126. \n                    https:\/\/doi.org\/10.1002\/ana.21429","journal-title":"Ann Neurol"},{"key":"9425_CR7","unstructured":"WHO (1998) Control and surveillance of African trypanosomiaisis. WHO technical report series,Geneva, vol 881, pp\u00a01\u2013113"},{"key":"9425_CR8","unstructured":"WHO (2018) Neglected diseases data interactive map. WHO|World Health Organization. \n                    https:\/\/apps.who.int\/neglected_diseases\/ntddata\/hat\/hat.html"},{"key":"9425_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fimmu.2019.00039","volume":"10","author":"PGE Kennedy","year":"2019","unstructured":"Kennedy PGE, Rodgers J (2019) Clinical and neuropathogenetic aspects of human African trypanosomiasis. Front Immunol 10:39. \n                    https:\/\/doi.org\/10.3389\/fimmu.2019.00039","journal-title":"Front Immunol"},{"key":"9425_CR10","doi-asserted-by":"publisher","first-page":"17716","DOI":"10.7554\/eLife.17716","volume":"5","author":"P Capewell","year":"2016","unstructured":"Capewell P, Cren-Travaille C, Marchesi F, Johnston P, Clucas C, Benson RA et al (2016) The skin is a significant but overlooked anatomical reservoir for vectorborne African trypanosomes. Elife 5:17716. \n                    https:\/\/doi.org\/10.7554\/eLife.17716","journal-title":"Elife"},{"key":"9425_CR11","volume-title":"The fatal sleep","author":"PGE Kennedy","year":"2010","unstructured":"Kennedy PGE (2010) The fatal sleep. Luath Press, Edinburgh"},{"key":"9425_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1179\/000349804225003406","volume":"98","author":"V Jamonneau","year":"2004","unstructured":"Jamonneau V, Ravel S, Garcia A, Koffi M, Truc P, Laveissiere C et al (2004) Characterization of Trypanosoma brucei s.l. infecting asymptomatic sleeping sickness patients in Cote d\u2019Ivoire: a new genetic group? Ann Trop Med Parasitol 98:329\u2013337. \n                    https:\/\/doi.org\/10.1179\/000349804225003406","journal-title":"Ann Trop Med Parasitol"},{"key":"9425_CR13","doi-asserted-by":"publisher","first-page":"e1691","DOI":"10.1371\/journal.pntd.0001691","volume":"6","author":"V Jamonneau","year":"2012","unstructured":"Jamonneau V, Ilboudo H, Kabore J, Kaba D, KoffiM Solano P et al (2012) Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl Trop Dis 6:e1691. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0001691","journal-title":"PLoS Negl Trop Dis"},{"key":"9425_CR14","doi-asserted-by":"publisher","first-page":"e3349","DOI":"10.1371\/journal.pntd.0003349","volume":"8","author":"D Sudarshi","year":"2014","unstructured":"Sudarshi D, Lawrence S, Pickrell WO, Eligar V, Walters R, Quaderi S et al (2014) Human African trypanosomiasis presenting at least 29 years after infection\u2013what can this teach us about the pathogenesis and control of this neglected tropical disease? PLoS Negl Trop Dis 8:e3349. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0003349","journal-title":"PLoS Negl Trop Dis"},{"key":"9425_CR15","doi-asserted-by":"publisher","first-page":"e0004608","DOI":"10.1371\/journal.pntd.0004608","volume":"10","author":"S Bisser","year":"2016","unstructured":"Bisser S, Lumbala C, Nguertoum E, Kande V, Flevaud L, Vatunga G et al (2016) Sensitivity and specificity of a prototype rapid diagnostic test for the detection of Trypanosoma brucei gambiense infection: a multi-centric prospective study. PLoS Negl Trop Dis 10:e0004608. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0004608","journal-title":"PLoS Negl Trop Dis"},{"key":"9425_CR16","doi-asserted-by":"publisher","first-page":"e0006386","DOI":"10.1371\/journal.pntd.0006386","volume":"12","author":"C Lumbala","year":"2018","unstructured":"Lumbala C, Bieler S, Kayembe S, Makabuza J, Ongarello S, Ndung\u2019u JM (2018) Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens. PLoS Negl Trop Dis 12:e0006386. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0006386","journal-title":"PLoS Negl Trop Dis"},{"key":"9425_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/trstmh\/trx034","volume":"111","author":"AK Njamnshi","year":"2017","unstructured":"Njamnshi AK, Gettinby G, Kennedy PGE (2017) The challenging problem of disease staging in human African trypanosomiasis (sleeping sickness): a new approach to a circular question. Trans R Soc Trop Med Hyg 111:199\u2013203. \n                    https:\/\/doi.org\/10.1093\/trstmh\/trx034","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"9425_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","volume":"374","author":"G Priotto","year":"2009","unstructured":"Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U et al (2009) Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 374:56\u201364. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)61117-X","journal-title":"Lancet"},{"key":"9425_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","volume":"391","author":"V Mesu","year":"2017","unstructured":"Mesu V, Kalonji WM, Bardonneau C, Mordt OV, Blesson S, Simon F et al (2017) Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. Lancet 391:144\u2013154. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)32758-7","journal-title":"Lancet"},{"key":"9425_CR20","unstructured":"European Medicines Agency (EMA). \n                    https:\/\/www.ema.europa.eu\/en\/fexinidazole-winthrop-h-w-2320"},{"key":"9425_CR21","doi-asserted-by":"publisher","first-page":"e1151","DOI":"10.1371\/journal.pntd.0001151","volume":"5","author":"RT Jacobs","year":"2011","unstructured":"Jacobs RT, Nare B, Wring SA, Orr MD, Chen D, Sligar JM et al (2011) SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis. PLoS Negl Trop Dis 5:e1151. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0001151","journal-title":"PLoS Negl Trop Dis"},{"key":"9425_CR22","doi-asserted-by":"publisher","first-page":"e1308","DOI":"10.1371\/journal.pntd.0001308","volume":"5","author":"J Rodgers","year":"2011","unstructured":"Rodgers J, Jones A, Gibaud S, Bradley B, McCabe C, Barrett MP et al (2011) Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis. PLoS Negl Trop Dis 5:e1308. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0001308","journal-title":"PLoS Negl Trop Dis"},{"key":"9425_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ijpara.2006.01.012","volume":"36","author":"PGE Kennedy","year":"2006","unstructured":"Kennedy PGE (2006) Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int J Parasitol 36:505\u2013512","journal-title":"Int J Parasitol"},{"key":"9425_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4269\/ajtmh.2011.10-0487","volume":"84","author":"J Rodgers","year":"2011","unstructured":"Rodgers J, McCabe C, Gettinby G, Bradley B, Condon B, Kennedy PGE (2011) Magnetic resonance imaging to assess blood-brain barrier damage in murine trypanosomiasis. Am J Trop Med Hyg 84:344\u2013350. \n                    https:\/\/doi.org\/10.4269\/ajtmh.2011.10-0487","journal-title":"Am J Trop Med Hyg"},{"key":"9425_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2017.06.015","author":"J Rodgers","year":"2017","unstructured":"Rodgers J, Bradley B (2017) Kennedy PGE (2018) Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasis. Methods. \n                    https:\/\/doi.org\/10.1016\/j.ymeth.2017.06.015","journal-title":"Methods"},{"key":"9425_CR26","doi-asserted-by":"publisher","first-page":"e2384","DOI":"10.1371\/journal.pntd.0002384","volume":"7","author":"E Myburgh","year":"2013","unstructured":"Myburgh E, Coles JA, Ritchie R, Kennedy PGE, McLatchie AP, Rodgers J, Taylor MC, Barrett MP, Brewer JM, Mottram JC (2013) In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis. PLoS Negl Trop Dis 7:e2384","journal-title":"PLoS Negl Trop Dis"},{"key":"9425_CR27","doi-asserted-by":"publisher","first-page":"e43913","DOI":"10.1371\/journal.pone.0043913","volume":"7","author":"U Frevert","year":"2012","unstructured":"Frevert U, Movila A, Nikolskaia OV, Raper J, Mackey ZB, Abdulla M et al (2012) Early invasion of brain parenchyma by African trypanosomes. PLoS ONE 7:e43913. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0043913","journal-title":"PLoS ONE"},{"key":"9425_CR28","doi-asserted-by":"publisher","first-page":"e906","DOI":"10.1371\/journal.pntd.0000906","volume":"4","author":"LM MacLean","year":"2010","unstructured":"MacLean LM, Odiit M, Chisi JE, Kennedy PG, Sternberg JM (2010) Focus specific clinical profiles in human African trypanosomiasis caused by Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis 4:e906. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0000906","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09425-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09425-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09425-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T23:05:21Z","timestamp":1592262321000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09425-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["9425"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09425-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"28 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I declare that I have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}